Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities - PubMed (original) (raw)

Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities

K E Bornfeldt et al. Diabetologia. 1991 May.

Abstract

Binding and growth promoting effects of insulin, insulin analogues modified in the B chain, proinsulin, insulin-like growth factor-I and -II were studied in cultured rat aortic smooth muscle cells. Specific binding of 125I-insulin was 0.9 +/- 0.2% of total 125I-insulin added, and the IC50-value was estimated to 8.9 pmol/l. The insulin analogue B10 Asp tended to be more potent than insulin in displacing 125I-insulin, B28 Asp was equipotent, B9 Asp/B27 Glu was approximately 100 times less potent and insulin-like growth factor-I more than 1000 times less potent than insulin. Specific binding of 125I-insulin-like growth factor-I after 4 h incubation at 10 degrees C was five times higher than the specific binding of insulin (4.4 +/- 0.4% of total 125I-insulin-like growth factor-I added), and the IC50-value was 0.3 nmol/l. Insulin was approximately 500 times less potent than insulin-like growth factor-I in displacing 125I-insulin-like growth factor-I. The insulin analogue B10 Asp was slightly more potent and analogue B28 Asp was equipotent with insulin. Analogue B9 Asp/B27 Glu was ten times less potent and proinsulin was more than ten times less potent than insulin. The order of potency was similar for 3H-thymidine incorporation into DNA: insulin-like growth factor-I greater than B10 Asp greater than insulin-like growth factor-II greater than insulin greater than or equal to B28 Asp greater than B9 Asp/B27 Glu greater than proinsulin. The maximal effect of insulin-like growth factor-I on 3H-thymidine incorporation was 71 +/- 16% higher than the maximal effect of insulin.(ABSTRACT TRUNCATED AT 250 WORDS)

PubMed Disclaimer

Cited by

Different proliferative responses of Gi/o-protein-coupled receptors in human myometrial smooth muscle cells. A possible role of calcium.
Nilsson UK, Grenegård M, Berg G, Svensson SP. Nilsson UK, et al. J Mol Neurosci. 1998 Aug;11(1):11-21. doi: 10.1385/JMN:11:1:11. J Mol Neurosci. 1998. PMID: 9826783
Insulin aspart.
Simpson KL, Spencer CM. Simpson KL, et al. Drugs. 1999 May;57(5):759-65; discussion 766-7. doi: 10.2165/00003495-199957050-00013. Drugs. 1999. PMID: 10353301 Review.
Insulin resistance, metabolic stress, and atherosclerosis.
Pansuria M, Xi H, Li L, Yang XF, Wang H. Pansuria M, et al. Front Biosci (Schol Ed). 2012 Jan 1;4(3):916-31. doi: 10.2741/s308. Front Biosci (Schol Ed). 2012. PMID: 22202099 Free PMC article. Review.
Timing-dependence of insulin-receptor mitogenic versus metabolic signalling: a plausible model based on coincidence of hormone and effector binding.
Shymko RM, Dumont E, De Meyts P, Dumont JE. Shymko RM, et al. Biochem J. 1999 May 1;339 ( Pt 3)(Pt 3):675-83. Biochem J. 1999. PMID: 10215607 Free PMC article.
Effects of new insulin analogues HMR1964 (insulin glulisine) and HMR1423 on insulin receptors.
Hennige AM, Strack V, Metzinger E, Seipke G, Häring HU, Kellerer M. Hennige AM, et al. Diabetologia. 2005 Sep;48(9):1891-7. doi: 10.1007/s00125-005-1870-8. Epub 2005 Jul 29. Diabetologia. 2005. PMID: 16052329

References

1. Biochem J. 1989 Feb 15;258(1):267-72 - PubMed
1. Exp Cell Res. 1983 May;145(2):231-7 - PubMed
1. In Vitro Cell Dev Biol. 1988 Sep;24(9):921-6 - PubMed
1. Proc Natl Acad Sci U S A. 1987 May;84(10):3254-8 - PubMed
1. Exp Cell Res. 1983 Feb;143(2):367-75 - PubMed

Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities - PubMed (original) (raw)